Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: Massachusetts General Hospital
This research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs involved in this study are: * obinutuzumab * venetoclax * acalabrutinib
This description comes directly from the study's public registry record.
Jacob D Soumerai, MD · 617-724-4000 · jsoumerai@mgh.harvard.edu
Jacob D Soumerai, MD · jsoumerai@mgh.harvard.edu
Always discuss trial participation with your own doctor first.
| Massachusetts General Hospital Cancer Center | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04560322